Kazakhstani startup CerebraAI among the top 15 AI companies in the US and Canada

CerebraAI, a company using artificial intelligence to analyze non-contrast computed tomography (CT) scans to improve the accuracy of stroke diagnosis and subsequent treatment, has joined Google for Startups Cloud AI Accelerator, a flagship program. This is one of Google’s most prestigious initiatives, selecting only 10–15 promising startups with advanced AI developments.

Participation in the accelerator provides CerebraAI with access to Google’s cloud resources for scaling, personalized mentoring from experts at Google DeepMind and Google Cloud, as well as leading global experts in artificial intelligence and machine learning.

Doszhan Zhusupov, Founder and CEO of CerebraAI
What we are doing at CerebraAI with non-contrast CT involves significant scientific and engineering risk. Without this, it is impossible to create real value for medicine. Therefore, we need any kind of support, and Google possesses the intellectual and technical resources to provide it. Interestingly, CerebraAI is the only medical technology company in this cohort of Google for Startups USA.

The Google for Startups Cloud AI Accelerator program offers participants:

— Individual mentoring from top Google specialists and AI industry leaders
— Access to Google Cloud technologies worth up to $350,000
— In-depth expert sessions on machine learning, product development, and strategic growth
— Early access to the latest Google tools, including Cloud TPU.

CerebraAI develops artificial intelligence-based software that analyzes non-contrast CT scans to bring their diagnostic quality closer to that of MRI and contrast-enhanced CT, opening up opportunities for early therapy and even personalized treatment for certain emergency conditions and oncology.

Learn more about the Google for Startups Cloud AI Accelerator program here.